Ensysce Biosciences, Inc.

US$0.33As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ENSCHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR (73.57%)
Div yield —
ROE (1295.09%)
Biotechnology
Beta (5Y) 1.09
PE TTM —
TSR TTM (84.92%)
Mkt cap US$6.395M
ROIC (615.61%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.403
22.52%
(14.87%)
Hold 0|8|12|4|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
0.01
0.01
0.01
9.41%
9.97%
25.68%
18.46%
Revenue$M
0.698
0.693
0.729
0.762
3.62%
1.63%
2.78%
8.92%
Peers (US$6.395M)
Cap (US$)
PE
6.316M
—
Capital
TTM
5Y
10Y
Leveragex
1.780
0.553
0.423
EBIT/Intx
0.358
0.790
0.703
Own earn%
21.13
26.71
36.60
Sh yield%
32.13
51.34
51.93
Owners
Insiders/Inst%
8.17
52.95
Short interest%
1.35
SBC / revenue%
5.53
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
13–17
$1 testx
—
Incr. ROIC%
3